Rhythm Pharmaceuticals' GAAP loss for 2021 was $69.612 million, down 48% from $133.996 million the previous year. Revenue was $3.154 million. The company had no revenue a year earlier.
Rhythm Pharmaceuticals' GAAP loss for 2021 was $69.612 million, down 48% from $133.996 million the previous year. Revenue was $3.154 million. The company had no revenue a year earlier. 
ir.rhythmtx.com
English (US) 